[
  {
    "ts": null,
    "headline": "Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal",
    "summary": "The drugmaker  Eli Lilly  reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug.  Lilly shares are up about 5% this year.  Lilly appears to have triumphed over  Novo Nordisk  in the battle for the weight-loss market.",
    "url": "https://finnhub.io/api/news?id=bf6bec0f82931e3858541c60fb40f3f6b7f4625a40e0d87b948b9c823502694c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761770700,
      "headline": "Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal",
      "id": 137263628,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The drugmaker  Eli Lilly  reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug.  Lilly shares are up about 5% this year.  Lilly appears to have triumphed over  Novo Nordisk  in the battle for the weight-loss market.",
      "url": "https://finnhub.io/api/news?id=bf6bec0f82931e3858541c60fb40f3f6b7f4625a40e0d87b948b9c823502694c"
    }
  },
  {
    "ts": null,
    "headline": "Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.",
    "summary": "Merck shares have floundered this year, as the company speeds like a whistling locomotive toward the expiration of the patents protecting its megablockbuster cancer immunotherapy Keytruda.  Executives have a shot at reassuring the market on Thursday, when the company reports its third quarter results, but analysts aren’t optimistic.  “We see a choppy 3Q print,” Cantor analyst Carter Gould wrote early this month.",
    "url": "https://finnhub.io/api/news?id=a9c0b56517010d48d9f40881152a0d323b44f87a4199e20eda53d58fa47bdc41",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761769800,
      "headline": "Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.",
      "id": 137263688,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Merck shares have floundered this year, as the company speeds like a whistling locomotive toward the expiration of the patents protecting its megablockbuster cancer immunotherapy Keytruda.  Executives have a shot at reassuring the market on Thursday, when the company reports its third quarter results, but analysts aren’t optimistic.  “We see a choppy 3Q print,” Cantor analyst Carter Gould wrote early this month.",
      "url": "https://finnhub.io/api/news?id=a9c0b56517010d48d9f40881152a0d323b44f87a4199e20eda53d58fa47bdc41"
    }
  },
  {
    "ts": null,
    "headline": "Berenberg Bank Maintains a Hold on Pfizer Inc (PFE), Ahead of Q3 Earnings",
    "summary": "​Pfizer Inc. (NYSE:PFE) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 27, Berenberg Bank analyst Luisa Hector maintained a Hold rating on Pfizer Inc. (NYSE:PFE) with a price target of $25. ​Earlier on October 22, Tim Andreson from Bank of America Securities reiterated a Hold rating with […]",
    "url": "https://finnhub.io/api/news?id=2e54361cbb7a7a5da504d5d4cbd554dd7b4d1f2a1a721eaec023ceb3524c5d24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761751089,
      "headline": "Berenberg Bank Maintains a Hold on Pfizer Inc (PFE), Ahead of Q3 Earnings",
      "id": 137258715,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "​Pfizer Inc. (NYSE:PFE) is one of the Best Stocks to Buy for High Returns Heading into 2026. On October 27, Berenberg Bank analyst Luisa Hector maintained a Hold rating on Pfizer Inc. (NYSE:PFE) with a price target of $25. ​Earlier on October 22, Tim Andreson from Bank of America Securities reiterated a Hold rating with […]",
      "url": "https://finnhub.io/api/news?id=2e54361cbb7a7a5da504d5d4cbd554dd7b4d1f2a1a721eaec023ceb3524c5d24"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock: Is Wall Street Bullish or Bearish?",
    "summary": "Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.",
    "url": "https://finnhub.io/api/news?id=6ed71f8304b3b9279a35c2807e622ea0a89b3bce72f078181af76cfab61795de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761744438,
      "headline": "Pfizer Stock: Is Wall Street Bullish or Bearish?",
      "id": 137258716,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.",
      "url": "https://finnhub.io/api/news?id=6ed71f8304b3b9279a35c2807e622ea0a89b3bce72f078181af76cfab61795de"
    }
  },
  {
    "ts": null,
    "headline": "Stock market: Yahoo Finance Invest features exclusive conversations on AI, crypto, and the economy",
    "summary": "At Yahoo Finance Invest, an influential lineup of leaders across business, politics, and finance will convene to discuss what's next in markets, AI, cryptocurrency, and more.",
    "url": "https://finnhub.io/api/news?id=06694a336657e9c4dd55ad4ca3b4e4b8887a8ea48b9360326d868ddf5363e67c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761743096,
      "headline": "Stock market: Yahoo Finance Invest features exclusive conversations on AI, crypto, and the economy",
      "id": 137248081,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "At Yahoo Finance Invest, an influential lineup of leaders across business, politics, and finance will convene to discuss what's next in markets, AI, cryptocurrency, and more.",
      "url": "https://finnhub.io/api/news?id=06694a336657e9c4dd55ad4ca3b4e4b8887a8ea48b9360326d868ddf5363e67c"
    }
  },
  {
    "ts": null,
    "headline": "What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?",
    "summary": "LLY's rapid dealmaking spree across biotech and gene therapy aims to expand its pipeline beyond cardiometabolic drugs and fuel long-term growth.",
    "url": "https://finnhub.io/api/news?id=9651fc7841b6f4616e872e12cdce75937ed36f9e10f2b9a0e6e56f031831dd89",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761740520,
      "headline": "What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?",
      "id": 137247828,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "LLY's rapid dealmaking spree across biotech and gene therapy aims to expand its pipeline beyond cardiometabolic drugs and fuel long-term growth.",
      "url": "https://finnhub.io/api/news?id=9651fc7841b6f4616e872e12cdce75937ed36f9e10f2b9a0e6e56f031831dd89"
    }
  },
  {
    "ts": null,
    "headline": "1 S&P 500 Stock to Target This Week and 2 We Brush Off",
    "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
    "url": "https://finnhub.io/api/news?id=d638671714530cab61bfad3d5d503b294501f5ec50bff6c8ebcaa7071a41679a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761712427,
      "headline": "1 S&P 500 Stock to Target This Week and 2 We Brush Off",
      "id": 137248083,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
      "url": "https://finnhub.io/api/news?id=d638671714530cab61bfad3d5d503b294501f5ec50bff6c8ebcaa7071a41679a"
    }
  }
]